India Prednisolone Market to grow at a steady rate During the Forecast Period
Increase in number of
allergies is expected to drive the growth of India prednisolone market during
the forecast period.
According
to TechSci Research report, “India Prednisolone Market By Form (Capsule,
Tablet, Injection, Syrup, Eye Drops), By Route of Administration (Oral,
Ophthalmic, Intravenous), By Distribution Channel (Online v/s Offline), By
Source (In-house v/s Contract Manufacturing Organizations), By Application
(Inflammation, Rheumatoid Arthritis, Acute Lymphoblastic Leukaemia, Autoimmune
Hepatitis and Others), By End User (Adult v/s Pediatric), By Company, By Region,
Forecast & Opportunities, FY2026”, the India prednisolone market is expected to grow at a
steady rate during the forecast period. Prednisolone is a steroid medication
which is utilized to treat certain types of allergies, inflammatory conditions,
autoimmune disorders, and cancers. This drug at times is also used in
combination with antibiotics to treat a certain type of pneumonia in patients
with acquired immunodeficiency syndrome.
This in turn is expected to fuel the market growth through FY2026. In
addition to this, multiple sclerosis disease is treated effectively with the
use of this drug API, thereby bolstering the market growth through 2025. However,
side-effects associated with drug consumption such as nausea, feeling tired, bone
loss, weakness, yeast infections, and easy bruising might restrict the market
growth over the next few years.
Figure 1: New Cancer Cases in India, (%), 2019
Source: TechSci Research
Browse XX market data Tables and XX
Figures spread through XXX
Pages and an in-depth TOC on " India Prednisolone
Market"
https://www.techsciresearch.com/report/india-prednisolone-market/7198.html
The India prednisolone market is segmented based on form, route of
administration, distribution channel, source, application, end user, company,
and region. Based on application, the market can be fragmented into inflammation,
rheumatoid arthritis, acute lymphoblastic leukemia, autoimmune hepatitis and
others. The rheumatoid arthritis segment is expected to register significant
growth in the market over the coming years on account of rising cases of autoimmune
conditions in the country. In terms of distribution channel, the market is
split into online and offline. The offline channel is expected to dominate the
market during the forecasted years as it is more suitable for the consumers to
buy medicines from a pharmacy in the vicinity. Based on source, the market can
be categorized into in-house v/s contract manufacturing organizations. The in-house
segment dominated the market until 2019 owing to the fact that keeping
manufacturing in-house provides a lot of flexibility to change the product.
Contract manufacturing organizations segment is expected to witness significant
growth in the market on account of high scalability of products coupled with considerable
growth in number of contract manufacturers in the country.
Cipla Ltd., Avik
Pharmaceutical Limited, Anuh Pharma Ltd., Neon Laboratories Limited,
Psychotropics India Limited, Nicholas Piramal India Ltd., Mankind Pharma Pvt.
Ltd., Macleods Pharmaceuticals Ltd., Allergan India Pvt. Ltd., Sanofi Aventis Pharma India Ltd., and
others are some of the leading players operating in India prednisolone market.
Companies operating in the market are using Go-to-Market strategies such as
product launches, mergers and acquisitions and research collaborations to boost
their share and increase their geographic reach.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7198
Customers can also
request for 10% free customization on this report.
“India prednisolone market is expected to
witness growth during the forecast period as it is used to treat tuberculous
meningitis. Also, prednisolone acetate ophthalmic suspension (eye drops) is used
to lessen swelling, itching, redness, and allergic reactions affecting the eye,
therefore it is further expected to create lucrative opportunities for the
market growth of India Prednisolone market over the next five years. This drug
API is sometimes used to treat the symptoms of certain types of cancer, which
is estimated to increase the demand of the drug in near future.” said
Mr. Karan Chechi, Research Director with TechSci Research, a research based India
management consulting firm.
“India Prednisolone Market By Form (Capsule, Tablet,
Injection, Syrup, Eye Drops), By Route of Administration (Oral, Ophthalmic,
Intravenous), By Distribution Channel (Online v/s Offline), By Source (In-house
v/s Contract Manufacturing Organizations), By Application (Inflammation,
Rheumatoid Arthritis, Acute Lymphoblastic Leukaemia, Autoimmune Hepatitis and
Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast
& Opportunities, FY2026”, has
evaluated the future growth potential of India prednisolone market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in India prednisolone market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]